Last update 07 Jun 2025

HSK46575

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
HSK46575
Target
CYP11A1
Action
inhibitors
Mechanism
CYP11A1 inhibitors(Cytochrome P450 11A1 inhibitors)
Therapeutic Areas
NeoplasmsUrogenital Diseases
Active Indication
Metastatic castration-resistant prostate cancerProstatic Cancer
Inactive Indication-
Originator Organization
Tibet Haisco Pharmaceutical Co. Ltd.
Active Organization
Haisco Pharmaceutical Group Co., Ltd.Haisco Pharmaceutical Group Co., Ltd.Tibet Haisco Pharmaceutical Co. Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

3
Clinical Trials associated with HSK46575
ChiCTR2400093403
/ SuspendedPhase 1IIT
Phase I clinical study to evaluate the safety, pharmacokinetics and efficacy of HSK46575 tablets in patients with metastatic castration-resistant prostate cancer (mCRPC)
NCT07007910
/ RecruitingPhase 1
A Phase I Clinical Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of HSK46575 Tablets in Patients With Metastatic Castration-Resistant Prostate Cancer
CTR20244620
/ RecruitingPhase 1
评价HSK46575片在转移性去势抵抗性前列腺癌（mCRPC）患者中的安全性、药代动力学及有效性的I期临床研究
[Translation] A phase I clinical study to evaluate the safety, pharmacokinetics and efficacy of HSK46575 tablets in patients with metastatic castration-resistant prostate cancer (mCRPC)
100 Clinical Results associated with HSK46575
Login to view more data
100 Translational Medicine associated with HSK46575
Login to view more data
100 Patents (Medical) associated with HSK46575
Login to view more data
100 Deals associated with HSK46575
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Metastatic castration-resistant prostate cancerPhase 1
China
Haisco Pharmaceutical Group Co., Ltd.Haisco Pharmaceutical Group Co., Ltd.
18 Dec 2024
Prostatic CancerIND Approval
China
Tibet Haisco Pharmaceutical Co. Ltd.
04 Dec 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free